
MET Inhibitor With Chemoimmunotherapy Overcomes Treatment Resistance in Some Patients With SCLC
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQaENMTlJXY0VhMXdBT1FIVkg2dDBaT3lva2ZObFVzaGNub0RYY0VOaUNjZXZrdGFHSU5McGlQNXVfeGRMdUJWTkt0U3NYYmlTQ2stS2FIU3hBcjJaTGFPQVVxU3gwb2ExVGg5Wlp5VUdIQVJQeWFSOXJvbU1pQVllT1BqR0pfaXpyVjJyT3otSEUwdXl4QlRfV3NlbFV3c2NUVHEtRktSMmJqaFhXQklEdTM5T05oYUFSeHJEMG1TdWdwc1NqNXo0dk5B?oc=5" target="_blank">MET Inhibitor With Chemoimmunotherapy Overcomes Treatment Resistance in Some Patients With SCLC</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmacy Times</font>